Electrolytes in Chronic Kidney Disease Patients With Acute Coronary Syndrome
Study of Serum Calcium and Phosphorus Level in Chronic Kidney Disease Patients With Acute Coronary Syndrome
1 other identifier
observational
100
1 country
1
Brief Summary
Study of serum calcium and phosphorus level in chronic kidney disease patients and its relation to occurrence of acute coronary syndrome in them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2021
CompletedFirst Posted
Study publicly available on registry
November 24, 2021
CompletedStudy Start
First participant enrolled
November 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedNovember 24, 2021
November 1, 2021
6 months
November 6, 2021
November 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Chronic kidney disease hospitalization
The CKD patient with and without acute coronary syndrome and estimated hazard ratios (HR) by use of multivariable Cox regression models.
from the day of admission to the day of discharge through study completion, an average of 28 weeks, in sohag university hospital
Study Arms (2)
Chronic Kidney Disease (CKD) patients with acute coronary syndrome
The CKD patients with or without dialysis who admitted to coronary care unit with chest pain consistent with ACS with any of following features : 1. Electrocardiogram (ECG) changes: * ST elevation. * ST depression. * T wave inversion. * recent left bundle branch block. 2. Troponin elevation.
Chronic Kidney Disease (CKD) patients without acute coronary syndrome
The CKD patient with or without dialysis with no previous history of ACS.
Interventions
* Serum calcium level. * Serum phosphorus level. will be measured to all study population
Eligibility Criteria
two groups : 1. CKD patients with and without dialysis who admitted to Sohag university hospital with acute coronary syndrome 2. CKD patients with and without dialysis who admitted to Sohag university hospital with no previous or current history of acute coronary syndrome
You may qualify if:
- The CKD patients with or without dialysis who admitted to coronary care unit with chest pain consistent with ACS with any of following features :
- a- Electrocardiogram (ECG) changes:
- ST elevation.
- ST depression.
- T wave inversion.
- recent left bundle branch block.
- b- Troponin T elevation.
- The CKD patient with or without dialysis with no previous history of ACS.
You may not qualify if:
- Patients who were diagnosed with primary hyperparathyroidism.
- Acute Kidney injury (AKI) which is defined as any of the following:(KDIGO2012)
- Increase in S.Cr by ≥ 0.3 mg/dl (≥ 26.5 μmol/l) within 48hours; or
- Increase in S.Cr to ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days;or
- Urine volume \<0.5 ml/kg/h for 6 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag university
Sohag, 82524, Egypt
Related Publications (1)
Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607-17. doi: 10.1053/ajkd.1998.v31.pm9531176.
PMID: 9531176BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 6, 2021
First Posted
November 24, 2021
Study Start
November 30, 2021
Primary Completion
May 30, 2022
Study Completion
May 30, 2022
Last Updated
November 24, 2021
Record last verified: 2021-11